Aditxt, Inc. Derivative, Fixed Interest Rate
Aditxt, Inc. (ADTX) had Derivative, Fixed Interest Rate of 8.50% as of 2023-11-24, per its 10-Q filed 2024-05-20.
Discontinued › Notes › Derivative Instrument Detail
us-gaap:DerivativeFixedInterestRate · last filed 2024-05-20
- 2023-11-24: Derivative, Fixed Interest Rate 8.50%.
| Period end | Derivative, Fixed Interest Rate |
|---|---|
| 2023-11-24 | 8.50% 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |